Arrivent BioPharma, Inc. (AVBP)
22.95
-0.14
(-0.61%)
USD |
NASDAQ |
Feb 20, 16:00
22.95
0.00 (0.00%)
After-Hours: 17:24
Arrivent BioPharma Shareholders Equity (Quarterly) : 305.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 48.81M |
| AIM ImmunoTech, Inc. | -6.077M |
| Bristol Myers Squibb Co. | 18.47B |
| Annexon, Inc. | 161.44M |
| Spruce Biosciences, Inc. | 5.386M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 326.56M |
| Total Liabilities (Quarterly) | 21.56M |
| Debt to Equity Ratio | 0.0002 |
| Current Ratio | 14.90 |
| Net Debt Paydown Yield | 0.01% |